Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study led by UCL (University College London) researchers and funded by the British Heart Foundation (BHF) and Barts Charity.
Researchers with the University of Florida have developed a novel method for priming the immune system to fight salmonella infection.
A comprehensive review into what we know about COVID-19 and the way it functions suggests the virus has a unique infectious profile, which explains why it can be so hard to treat and why some people experience so-called "long-COVID". There is growing evidence that the virus infects both the upper and lower respiratory tracts - unlike "low" or "high" pathogenic" human coronavirus sub-species, which typically settle in one or the other.
Patients with lasting symptoms of COVID-19 who completed a six week, supervised rehabilitation programme demonstrated significant improvements in exercise capacity, respiratory symptoms, fatigue and cognition.
The use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, does not lead to higher rates of death or severe disease in patients who are hospitalised with COVID-19, according to a new observational study of more than 72,000 people in the UK published in The Lancet Rheumatology journal.
After the most comprehensive review to date, a panel of leading medical experts conclude that ivermectin should be systematically and globally adopted for the prevention and treatment of COVID-19.
In a new position statement, Alzheimer Europe has issued a call for prioritization of people with dementia and their carers in national COVID-19 vaccination strategies, urging governments to recognize the disproportionate effect of the pandemic on these groups.
A team of environmental engineers, alerted by the unusual wealth of data published regularly by county health agencies throughout the pandemic, began researching new methods to describe what was happening on the ground in a way that does not require obtaining information on individuals' movements or contacts. In a recently published paper, they presented their results: a model that predicts where the disease will spread from an outbreak, in what patterns and how quickly.
Story tip from Johns Hopkins experts on COVID-19.
In a study published today in the Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2 -- the virus that causes COVID 19 -- confers some protection for people who have received solid organ transplants, it's still not enough to enable them to dispense with masks, physical distancing and other safety measures.